Chemoradiation in anaplastic thyroid carcinomas.

@article{Sun2013ChemoradiationIA,
  title={Chemoradiation in anaplastic thyroid carcinomas.},
  author={Xu Shan Sun and Shi-yong R Sun and Nicolas Guevara and N Fakhry and Pierre Yves Marcy and Sandra Lassalle and Isabelle Peyrottes and Ren{\'e} Jean Bensadoun and Alexis Lacout and Jos{\'e} Santini and Laurent Cals and J F Bosset and Adam Seth Garden and Juliette Thariat},
  journal={Critical reviews in oncology/hematology},
  year={2013},
  volume={86 3},
  pages={290-301}
}
BACKGROUND ATC represents 1-2% of all thyroid carcinomas. Median survival is poor (3-10 months). Our goal is to update recommendations for RT in the context of new irradiation techniques. MATERIALS AND METHODS A search of the French and English literature was performed with terms: thyroid carcinoma, anaplastic, chemoradiation, radiation therapy and surgery. Level-based evidence remains limited in the absence of prospective studies and the small size of retrospective series of this rare tumor… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

Similar Papers

Loading similar papers…